Marker Therapeutics, Inc. (MRKR)

2.00 -0.07 (-3.38%) USD  |  NASDAQ  |  Jan 09, 16:00
2.05 +0.05 (+2.50%) After-Hours: 20:00
More

Marker Therapeutics Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
Neurocrine Biosciences, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
AIM ImmunoTech, Inc. Upgrade